Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy (2022)

First Author: Symeonidou V
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jha2.527

PubMed Identifier: 36051087

Publication URI: http://europepmc.org/abstract/MED/36051087

Type: Journal Article/Review

Parent Publication: eJHaem

Issue: 3

ISSN: 2688-6146